3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
5
Recurrence
3
Neoplasm Metastasis
3
Melanoma
3
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Cutaneous Squamous Cell Carcinoma
2
Carcinoma, Basal Cell
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Ovarian Neoplasms
1
Neoplasms
1
Multiple Myeloma
1
Lymphoma
1
Head and Neck Neoplasms
1
Glioma
1
Glioblastoma
1
Diffuse Intrinsic Pontine Glioma
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Squamous Cell
1
Carcinoma, Merkel Cell
1
Breast Neoplasms
1
Advanced Non-Small Cell Lung Carcinoma
1
Adenocarcinoma
1
Interventions
vandetanib
9
cabozantinib
6
selpercatinib
4
Sorafenib
3
Sunitinib
2
Magnetic Resonance Spectroscopy
2
yeast-CEA vaccine
1
tanespimycin
1
rovalpituzumab tesirine
1
pralsetinib
1
pembrolizumab
1
pazopanib
1
lenvatinib
1
Vorinostat
1
Temozolomide
1
Specimen Handling
1
Pharmacogenomic Testing
1
Nivolumab
1
Lithium Carbonate
1
Irinotecan
1
Gefitinib
1
Ferrosoferric Oxide
1
Dexamethasone
1
Capecitabine
1
Bortezomib
1
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Medullary
×
cemiplimab
×
Clear all
No trials found.